Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.

Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.

Oncogene. 2006 Aug 31;25(39):5405-15. Epub 2006 Apr 24.

PMID:
16636674
3.

The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.

Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.

Oncogene. 2008 Jan 10;27(3):366-77. Epub 2007 Jul 16.

PMID:
17637753
4.
5.

AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene.

Williams CM, Scibetta AG, Friedrich JK, Canosa M, Berlato C, Moss CH, Hurst HC.

EMBO J. 2009 Nov 18;28(22):3591-601. doi: 10.1038/emboj.2009.290. Epub 2009 Oct 1.

6.

Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.

Nolens G, Pignon JC, Koopmansch B, Elmoualij B, Zorzi W, De Pauw E, Winkler R.

Breast Cancer Res. 2009;11(6):R83. doi: 10.1186/bcr2450. Epub 2009 Nov 11.

7.

AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.

Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.

Oncogene. 2004 Oct 28;23(50):8238-46.

PMID:
15378019
8.

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.

Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, Kang WK, Wang XF, Kim SJ, Trepel JB.

J Biol Chem. 1998 Apr 24;273(17):10618-23.

9.

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.

Mol Cell Biol. 2000 Oct;20(19):7059-67.

10.

Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.

Ailan H, Xiangwen X, Daolong R, Lu G, Xiaofeng D, Xi Q, Xingwang H, Rushi L, Jian Z, Shuanglin X.

BMC Cancer. 2009 Aug 11;9:279. doi: 10.1186/1471-2407-9-279.

12.

2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression.

Trautwein C, Will M, Kubicka S, Rakemann T, Flemming P, Manns MP.

Oncogene. 1999 Nov 11;18(47):6443-53.

13.

IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.

Zuo S, Liu C, Wang J, Wang F, Xu W, Cui S, Yuan L, Chen X, Fan W, Cui M, Song G.

J Cancer Res Clin Oncol. 2012 Jun;138(6):1045-55. doi: 10.1007/s00432-012-1153-y. Epub 2012 Mar 6.

PMID:
22392074
14.
15.

The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.

Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B.

Gynecol Oncol. 2006 Mar;100(3):462-8. Epub 2005 Oct 10.

PMID:
16216317
16.

Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.

Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.

Exp Cell Res. 1997 Aug 1;234(2):293-9.

PMID:
9260897
17.

Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.

Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H, Rajpert-De Meyts E.

Clin Cancer Res. 2004 Dec 15;10(24):8521-30.

19.

Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.

Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM.

Int J Radiat Biol. 1999 Mar;75(3):301-16.

PMID:
10203181
Items per page

Supplemental Content

Write to the Help Desk